Abstract

Aim:To investigate the size-dependent lymphatic uptake of nanoparticles in mice with rapidly growing syngeneic tumors.Materials & methods:Mice were inoculated subcutaneously with EL4 lymphoma cells and on day 5 or day 6 of tumor growth, injected peritumorally with either 29 nm or 58 nm of ultra-small superparamagnetic iron oxide nanoparticles. Twenty-four hours later the animals were imaged using MRI.Results & conclusion:The larger of the two particles can only be detected in the lymph node when injected in animals with 6-day-old tumors while the 29 nm ultra-small superparamagnetic iron oxide nanoparticle is observed on both time points. Tumor mass greatly impacts the size of particles that are transported to the lymph nodes.

Highlights

  • Mice inoculated with rapidly growing EL4 tumors were injected peritumorally with either of two sizes of ultra small superparamagnetic iron oxide nanoparticles (USPIOs)

  • The particles were administered on either day 5 or day 6 of tumor growth

  • It is quite possible that the treatment of several other types of cancer could benefit from this type of procedure and contrast agent, breast cancer and malignant melanoma, which are the most frequently used at present

Read more

Summary

Objectives

To investigate the size-dependent lymphatic uptake of nanoparticles in mice with rapidly growing syngeneic tumors. This study aims to improve the way the spreading of certain forms of cancer is detected

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.